The management of Neurofibromatosis type 1 (NF1) in children and adolescents

IF 3.4 2区医学 Q2 CLINICAL NEUROLOGY

Expert Review of Neurotherapeutics Pub Date : 2024-02-26 DOI:10.1080/14737175.2024.2324117

Nino Kerashvili, David H. Gutmann

引用次数: 0

Abstract

Neurofibromatosis type 1 (NF1) is a rare neurogenetic disorder characterized by multiple organ system involvement and a predisposition to the development of benign and malignant tumors. With revisi...

查看原文本刊更多论文

儿童和青少年神经纤维瘤病 1 型 (NF1) 的管理

神经纤维瘤病 1 型（NF1）是一种罕见的神经遗传性疾病，其特点是累及多个器官系统，并易发展成良性和恶性肿瘤。随着研究的不断深入...

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Expert Review of Neurotherapeutics Medicine-Neurology (clinical)

CiteScore

7.00

自引率

2.30%

发文量

审稿时长

4-8 weeks

期刊介绍： Expert Review of Neurotherapeutics (ISSN 1473-7175) provides expert reviews on the use of drugs and medicines in clinical neurology and neuropsychiatry. Coverage includes disease management, new medicines and drugs in neurology, therapeutic indications, diagnostics, medical treatment guidelines and neurological diseases such as stroke, epilepsy, Alzheimer''s and Parkinson''s. Comprehensive coverage in each review is complemented by the unique Expert Review format and includes the following sections: Expert Opinion - a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results Article Highlights – an executive summary of the author’s most critical points